Residents with any information have been urged to contact the concerned authority
emergencies7 hours ago
Covid-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the Covid-19 causing virus, which were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.
The study by Oxford University researchers, published in the journal Cell, investigated the ability of antibodies in the blood from people, who were vaccinated with the two-shot regimens, to neutralise the highly contagious Delta and Kappa variants, a statement said.
"There is no evidence of widespread escape suggesting that the current generation of vaccines will provide protection against the B.1.617 lineage," the paper said, referring to the Delta and Kappa variants by a commonly used code.
However, the concentration of neutralising antibodies in the blood was somewhat reduced, which may lead to some breakthrough infections, they cautioned.
Last week, an analysis by the Public Health England (PHE) showed that vaccines made by Pfizer Inc and AstraZeneca offer high protection of more than 90 per cent against hospitalization from the Delta variant.
"We are encouraged to see the non-clinical results published from Oxford and these data, alongside the recent early real-world analysis from Public Health England, provide us with a positive indication that our vaccine can have significant impact against the Delta variant," AstraZeneca executive Mene Pangalos said in a separate statement.
The Delta variant is becoming the globally dominant version of the disease, the World Health Organization's chief scientist said on Friday.
The Oxford researchers also analysed reinfection patterns in people who had previously had Covid-19.
The risk of reinfection with the Delta variant appeared particularly high in individuals previously infected by the Beta and Gamma lineages that emerged in South Africa and Brazil, respectively.
By contrast, previous infection with the Alpha, or B117, variant first detected in Britain, conferred "reasonable" cross-protection against all variants of concern, lending itself as a template that next-generation vaccines could be molded on.
"B117 might be a candidate for new variant vaccines to provide the broadest protection," the researchers said.
Residents with any information have been urged to contact the concerned authority
emergencies7 hours ago
Northeastern University in Boston says the action was taken after some protesters resorted to virulent anti-Semitic slurs
world8 hours ago
The church has been built on 4.37 acres of land, and stands opposite the BAPS Hindu temple
uae8 hours ago
A detailed guide on where to apply, the steps involved, and criteria for eligibility
uae8 hours ago
The Emirates called for strengthening the international humanitarian response and providing urgent relief to those in need
mena8 hours ago
Photonics is the study of light and has several applications including LED, VR, holograms, high-speed internet and solar panels among other things
uae9 hours ago
A delegation from Egypt arrived in Israel on Friday hoping to revive the truce negotiations
mena9 hours ago
The decision aims to protect the safety and security of pilgrims
gulf10 hours ago